Published in Sabouraudia on July 01, 1974
Cryptococcosis of lumbar vertebra in a patient with rheumatoid arthritis and scleroderma: case report and literature review. BMC Infect Dis (2013) 0.79
Cryptococcal pyarthrosis and sarcoidosis. Skeletal Radiol (2009) 0.78
Cryptococcal infection of the lumbar spine. J R Soc Med (1989) 0.77
Skeletal cryptococcosis: Case report and review of the literature. Can J Infect Dis (1996) 0.75
Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N Engl J Med (1968) 4.38
Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clinimycin. Am J Med Sci (1968) 3.78
5-Fluorocytosine in human cryptococcosis. Antimicrob Agents Chemother (Bethesda) (1968) 3.08
Progressive disseminated histoplasmosis. A prospective study of 26 patients. Ann Intern Med (1972) 1.99
Therapy of cryptococcosis with a combination of flucytosine and amphotericin B. J Infect Dis (1975) 1.88
Primary amoebic meningoencephalitis caused by Naegleria. Two new cases, response to amphotericin B, and a review. Ann Intern Med (1971) 1.79
Aspergillus species endocarditis. The new face of a not so rare disease. Am J Med (1974) 1.74
In vitro susceptibility of Cryptococcus neoformans to amphotericin B, hamycin, and 5-fluorocytosine. Antimicrob Agents Chemother (Bethesda) (1968) 1.62
North American blastomycosis: a study of 40 patients. Medicine (Baltimore) (1968) 1.56
Chemotherapeutic agents for the pulmonary mycoses. Report of the Committee on Fungus Diseases and Subcommittee on Therapy, American College of Chest Physicians. Chest (1971) 1.53
Preliminary studies on a hyphaforming mutant of Cryptococcus neoformans. Mycologia (1966) 1.46
Thoracic cross-sectional imaging of amyloidosis. AJR Am J Roentgenol (1997) 1.35
Meningoencephalitis due to pathogenic free-living amoebae. Report of two cases. JAMA (1968) 1.30
Intraventricular administration of amphotericin B. Use of subcutaneous reservoir in four patients with mycotic meningitis. JAMA (1965) 1.28
5-fluorocytosine in human candidiasis. Antimicrob Agents Chemother (Bethesda) (1970) 1.22
Unexplained pulmonary hypertension in chronic myeloproliferative disorders. Chest (2001) 1.20
Cryptococcosis complicating sarcoidosis. Am Rev Respir Dis (1973) 1.12
Epidemic of pulmonary blastomycosis (Namekagon fever) in Wisconsin canoeists. Chest (1984) 1.12
Rifampin: antibacterial activity in vitro and absorption and excretion in normal young men. Am J Med Sci (1970) 1.09
Clinical features of extracutaneous sporotrichosis. Medicine (Baltimore) (1967) 1.08
Flucytosine. N Engl J Med (1972) 1.04
An evaluation of measles and smallpox vaccines simultaneously administered. Am J Public Health Nations Health (1967) 1.04
Therapeutic bronchoscopy in broncholithiasis. Am J Respir Crit Care Med (1999) 1.04
Risk of osteoporotic fractures in women with breast cancer: a population-based cohort study. J Chronic Dis (1987) 0.99
Meningoencephalitis due to hyphae-forming Cryptococcus neoformans. Am J Clin Pathol (1971) 0.99
Clinical and laboratory studies of a new micronized preparation of hamycin in systemic mycoses in man. Antimicrob Agents Chemother (Bethesda) (1967) 0.99
External-beam radiation therapy in the treatment of diffuse tracheobronchial amyloidosis. Mayo Clin Proc (2001) 0.99
Sarcoidosis presenting as a central nervous system mass lesion. Chest (1997) 0.97
Brain abscess caused by Cladosporium trichoides. Arch Intern Med (1976) 0.97
Cavitary pulmonary infarct in immunocompromised hosts. Mayo Clin Proc (1995) 0.97
Pulmonary hypertension in patients with amyloidosis. Chest (2001) 0.97
Cardiac echinococcosis: case report of unusual echocardiographic appearance. Mayo Clin Proc (1995) 0.91
Chemotherapy for the systemic mycoses: the prelude to ketoconazole. Rev Infect Dis (1981) 0.90
New drugs for the systemic mycoses: flucytosine and clotrimazole. Bull N Y Acad Med (1975) 0.89
Chemotherapy of the systemic mycoses. Med Clin North Am (1982) 0.88
Viruria in man, an update. Prog Med Virol (1974) 0.88
Hamycin: chemotherapeutic studies in systemic mycoses of man. Am Rev Respir Dis (1967) 0.88
In vitro and in vivo activity of hamycin against Blastomyces dermatitidis. J Bacteriol (1969) 0.86
Candida meningitis. Arch Intern Med (1966) 0.85
Intraoperative mitomycin-C for glaucoma associated with ocular inflammation. Ophthalmic Surg Lasers (1997) 0.82
Cryptococcal pyelonephritis. N Engl J Med (1968) 0.82
Nosocomial infections acquired by hospital employees. Infect Control (1981) 0.82
The current status of chemotherapeutic agents for the systemic mycoses. Contrib Microbiol Immunol (1977) 0.81
Pulmonary infection due to opportunistic fungi. Adv Intern Med (1970) 0.79
The CDC guidelines for prevention and control of nosocomial infections: view from the trenches. Am J Infect Control (1985) 0.78
Pediatric tracheobronchial foreign bodies. A case report. Minn Med (1993) 0.78
Fungal infections of the central nervous system. Clin Neurosurg (1966) 0.76
Histoplasma and cryptococcus meningitis. Res Publ Assoc Res Nerv Ment Dis (1968) 0.76
In Vivo Susceptibility of Cryptococcus neoformans to Hamycin, Amphotericin B, and 5-Fluorocytosine. Infect Immun (1970) 0.75
Troubles in sporotrichosis. N Engl J Med (1969) 0.75
Cryptococcus neoformans and cryptococcosis. Trans Am Clin Climatol Assoc (1970) 0.75
Re-using disposables--a medico-legal view. Hosp Infect Control (1978) 0.75
The law and infection control. Immunizations: part II. Infect Control (1981) 0.75
Disruption of family unity from an adverse reaction to tetracycline. Infect Control (1982) 0.75
Hospital-acquired staphylococcal infection transmitted by hospital personnel. Infect Control (1981) 0.75
50-year-old man with fever and rhinorrhea. Mayo Clin Proc (1995) 0.75
Infection control committee minutes--revisited. Infect Control (1984) 0.75
Reducing amphotericin B reactions. 3. Use of a preparation with increased phosphate buffer. Am Rev Respir Dis (1965) 0.75
Factors predisposing to illness. Mod Treat (1970) 0.75
Chemotherapy of the systemic mycoses. Am Fam Physician (1973) 0.75
Legal aspects of antibiotic audit. Infect Control (1984) 0.75
Sarah Elizabeth Stewart. Cancer Res (1977) 0.75
Indications for chemotherapy in the pulmonary mycoses. A report of the Committee on Fungus Diseases, Subcommittee on Therapy, American College of Chest Physicians. Dis Chest (1969) 0.75
The law and infection control. The myth of negligence. Infect Control (1981) 0.75
The polypeptide antifungal agent (X-5079C): further studies in 39 patients. Am Rev Respir Dis (1966) 0.75
Fungal infections. Clin Pharmacol Ther (1974) 0.75
Antimicrobial therapy in systemic fungal infections. Am J Med (1965) 0.75
Staphylococcal infection in hospital roommates. Infect Control (1982) 0.75
Infection control committee records. Infect Control (1982) 0.75
Mechanotherapist wins on license. J Leg Med (N Y) (1976) 0.75
Yellow fever vaccine and avian leukosis virus. Ann Intern Med (1984) 0.75
Pulmonary lymphoproliferative disorders. Mayo Clin Proc (1993) 0.75
Legal aspects of endoscopy probed: instrument classification, standard of care questioned. Same Day Surg (1978) 0.75
To dig I am not able. N Engl J Med (1972) 0.75
Recognition and current management of the systemic mycoses. Med Clin North Am (1967) 0.75
Existence of Sporothrix schenckii as a pulmonary saprophyte. Chest (1978) 0.75
Current and future chemotherapy of central nervous system fungal infections. Adv Neurol (1974) 0.75
Liability of the pathology laboratory: a review of some legal cases involving hospital pathologists. Med Leg Bull (1980) 0.75
Round table on antifungal agents. Antimicrob Agents Chemother (Bethesda) (1965) 0.75
The law and infection control. Infect Control (1981) 0.75
55-year-old man with a lung lesion and hemidysesthesia. Mayo Clin Proc (1999) 0.75
Assay of antifungal agent saramycetin (X-5079C) in patient body fluids. Am Rev Respir Dis (1969) 0.75
Hamycin toxicity in the dog. Antimicrob Agents Chemother (Bethesda) (1965) 0.75
Surveillance technique: a wound study sheet. Hosp Infect Control (1978) 0.75